Navigation Links
Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
Date:2/17/2009

HONG KONG, Feb. 17 /PRNewswire-FirstCall/ -- Doctors in Hong Kong have carried out the first treatments in south-east Asia using a new, faster form of radiotherapy that extends more advanced care to more patients. A 74-year- old patient with localized prostate cancer became the region's first patient to receive treatment using RapidArc radiotherapy technology from Varian Medical Systems (NYSE: VAR).

Clinicians at the Pamela Youde Nethersole Eastern Hospital (PYNEH) in Hong Kong said they were delighted with the first treatment, which took just two to three minutes to deliver, much faster than conventional IMRT (intensity modulated radiotherapy) treatments. "IMRT treatments are time-consuming because tumors are targeted by a complex sequence of fixed radiation beams from multiple angles but the RapidArc treatment is dramatically faster," said Dr. T.K.Yau, consultant radiation oncologist.

"With this new technology, cancer patients in Hong Kong can receive a faster, more comfortable and more precise radiotherapy treatment," he added. "The RapidArc treatment can produce comparable or even better dose conformity compared with IMRT treatments but with shorter treatment times. It means that more of our patients can be treated with advanced IMRT-quality treatments."

Dr. Yau said the hospital now plans to expand the range of RapidArc treatments to include other pelvic tumors and head & neck cancers. PYNEH is one of six public cancer centers in Hong Kong.

RapidArc, which delivers a precise and efficient treatment in a single or multiple arcs of the treatment machine around the patient, was introduced early last year by Varian, the world leader in radiation therapy equipment and software. Since its launch, more than 70 hospitals worldwide have commenced clinical treatments and PYNEH is the first in the South-East Asia region, just as it was the first to introduce image-guided radiotherapy (IGRT) to Hong Kong in 2006.

Doctors at PYNEH treat patients using three Varian linear accelerators including a Clinac(R) 23Ex accelerator equipped with RapidArc radiotherapy technology, as acquired in 2008 thanks to a private donation. Dr. Yau says his department plans to equip a second accelerator with RapidArc in the coming months.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Final Economic Stimulus Bill Permits Americans Personal Health Information to Be Sold for Research and Public Health Purposes WITHOUT Patients Consent
2. Sponsor Dollars Key to Flu Vaccine Study Publication
3. URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
4. Six In 10 Americans Support Opening Medicare as a "Public Option" to the Private Insurance Market; Public Willing to Pay Through Payroll Deductions
5. Congressional Leaders, Public Health Experts Announce New Framework to Promote Womens Health
6. Laid Off Public Health Workers Excluded From Senate Stimulus, Governmental Health Laboratories Slammed by Recession
7. Over 170 Groups Urge Bill Conferees to Include Double Duty Public Health Funds in Stimulus for Jobs and Health Care Savings
8. Shawn Hanley Named KePRO Director of Business Development - Public Programs
9. Official Launch of ABLE TO CHOOSE Public Awareness Campaign
10. APHA Urges Congress to Include Public Health Provision in Stimulus Bill
11. FDA Fails to Protect Public: Remains Silent About Lead in Lipstick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... the Peace Agreements being discussed by President Donald Trump and the rest of the ... to speed up peace talks in the continuous battle between Israel and Palestine. The ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “When the ... Lead Home” is the creation of published author Laura Weigel Douglas, an avid reader ... cat in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: ... many others. “Cactus Jack: Against All Odds” is the creation of published author, ... Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Dr. Alan ... surgery in New York City. He is known for his distinguished expertise and ... vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic ...
(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/11/2017)...  Thornhill Research Inc. ( Toronto, Ontario, ... USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. ... (CCC) ( Ottawa, Ontario, Canada ) ... anesthesia to patients requiring emergency medical procedures in ... Corps have been a longtime partner with Thornhill ...
Breaking Medicine Technology: